TD Asset Management
AMAG

TD Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

TD Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,650
Closed -$252K – 1402
2015
Q2 		$252K Sell
3,650
-800
-18% -$50.3K ﹤0.01% 1310
2015
Q1 		$243K Buy
+4,450
New +$212K ﹤0.01% 1301
2014
Q2 		– Sell
-31,000
Closed -$600K – 1322
2014
Q1 		$600K Sell
31,000
-3,800
-11% -$80.7K ﹤0.01% 991
2013
Q4 		$845K Sell
34,800
-15,000
-30% -$353K ﹤0.01% 909
2013
Q3 		$1.07M Buy
49,800
+3,200
+7% +$75.6K ﹤0.01% 861
2013
Q2 		$1.04M Buy
+46,600
New +$1.03M ﹤0.01% 841

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TD Asset Management's AMAG Position: Q3 2015 in Review

TD Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 3,650 shares — an estimated $252K sold.

TD Asset Management first reported a position in AMAG in Q2 2013 and held it in 6 quarters. The position peaked at $1.07M in Q3 2013. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • TD Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • TD Asset Management sold 3,650 AMAG Pharmaceuticals shares in Q3 2015, an estimated $252K.
  • TD Asset Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • TD Asset Management's AMAG Pharmaceuticals position peaked at $1.07M in Q3 2013.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on TD Asset Management's 13F filing for Q3 2015, filed 12 Nov 2015.